Weifa ASA : Reminder - Invitation to presentation of Weifa ASA

Oslo, 28 August 2014

Weifa ASA (OSE: WEIFA), Norway's leading  fully-integrated pharmaceutical company, is hosting a presentation of the company for investors, analysts, press and other interested parties, on 2 September at  Felix Konferansesenter, Bryggetorget 3, Oslo, Norway. 

Following an introduction by the Chairman, Glen Rødland, the company will be presented by Kjell-Erik Nordby, CEO, and Gunnar Manum, CFO. 

The presentation will start at 09:30, and last for approx. 1 hour.

Following the presentation, there will be a Q&A session.

No pre-registration required.   

Weifa welcomes all interested parties.

For further information, please contact:

Gunnar Manum
CFO
+47 95 17 91 90
gunnar.manum@aqualis.no

Weifa ASA (formerly Aqualis ASA) has, through the recent acquisition of Weifa AS, become Norway's leading fully-integrated pharmaceutical company and a major supplier of active ingredients to the international pharmaceutical industry. Weifa currently has approx. 180 employees, is headquartered in Oslo and has two manufacturing plants in Kragerø in southern Norway. Weifa's Consumer Health business holds well-known Norwegian brands such as Paracet, Ibux and Paralgin Forte.